Central Core Disease (CCD)
|
RyR1 > 90% CACNA1S
|
AD or AR |
-
✓
Centrally located, well-demarcated cores, spanning the whole fiber axis
Predominance in type 1 fibers
Increased central nuclei [133]
|
|
Multiminicore Disease (MMD)
|
RyR1
CACNA1S
|
AR |
-
✓
Numerous cores in a limited area on longitudinal section
Multiple internally located nuclei
Predominance in type 1 fibers [133,134,135,136]
|
|
Centronuclear Myopathy (CNM)
|
RyR1~12% |
AR |
|
|
Congenital Fibre Type Disproportion (CFTD)
|
RyR1~20% |
AR |
-
✓
Fiber size disproportion (35–40% of type 1 fibers are smaller in size than type 2 fibers)
Age-related development of rods, cores, and central nuclei [133,134,135,136]
|
|
Dusty Core Disease (DUCD)
|
RyR1
|
AR |
-
✓
Irregularly sized/shaped “Dusty” cores (reddish-purple granular material deposition) spanning 10 to 50 sarcomeres
Myofibrillar disorganization [133,134,135,136]
|
|
Core Rod Myopathy (CRM)
|
RyR1
|
AD or AR |
-
✓
Nemaline bodies (rods), clustered or widely distributed along the fibers
Central cores [133,134,135,136]
|
-
✓
Non-specific clinical features, including: hypotonia, muscle weakness, scoliosis, and respiratory insufficiency
|
Malignant Hyperthermia (MH)
|
RyR1
CACNA1S
STAC3
|
AD |
|
|